Abstract
In order to assess the effect of cyclandelate on the abnormal permeability of the blood-retinal barrier which occurs in diabetic patients before any other lesions are apparent in the retina a well-controlled, double blind, and paired trial was carried out in 22 patients. The treatments were randomised. The permeability of the blood-retinal barrier was assessed by vitreous fluorophotometry. Each patient was examined before being involved in the trial and then another 3 times with 1 month's interval. The total duration of treatment was 3 months. The results showed that the breakdown of the blood-retinal barrier as evidenced by the degree of abnormal fluorescein penetration into the vitreous suffered a significant decrease in the diabetic patients treated with cyclandelate when compared to the patients submitted to placebo administration, and this effect is particularly apparent in the third month of treatment.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ball J. A., Taylor A. R. Effect of cyclandelate on mental function and cerebral blood flow in elderly patients. Br Med J. 1967 Aug 26;3(5564):525–528. doi: 10.1136/bmj.3.5564.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DITZEL J., ROOTH G. The micro-angiopathy in diabetes mellitus; a concept regarding the mechanism of its origin. Diabetes. 1955 Nov-Dec;4(6):474–476. doi: 10.2337/diab.4.6.474. [DOI] [PubMed] [Google Scholar]
- Funcke A. B., van Beek M. C., Nijland K. Protective action of cyclandelate in hypoxia. Curr Med Res Opin. 1974;2(1):37–42. doi: 10.1185/03007997409111739. [DOI] [PubMed] [Google Scholar]
- Kuhn R. A. Effect of cyclandelate upon cerebral blood flow in patients with "stroke". Angiology. 1966 Jun;17(6):422–430. doi: 10.1177/000331976601700609. [DOI] [PubMed] [Google Scholar]
- O'Brien M. D., Veall N. Effect of cyclandelate on cerebral cortex perfusion-rates in cerebrovascular disease. Lancet. 1966 Oct 1;2(7466):729–730. doi: 10.1016/s0140-6736(66)92983-7. [DOI] [PubMed] [Google Scholar]